Physician profile
Carly Strus
NPI 1336616713
$422.56
in general payments reported to CMS, 2019-2025
9 companies · $91.41 in 2025
The $91.41 reported for 2025 was less than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.64 · 2022: $31.05 · 2023: $103 · 2024: $184 · 2025: $91.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $278 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $277.88 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $155.23 | 2024 | Veozah |
| Lilly USA, LLC | $67.03 | 2025 | Zepbound |
| Exeltis, USA INC. | $51.73 | 2023-2024 | Slynd |
| Myriad Women'S Health, INC. | $43.35 | 2023 | Myrisk |
| Idorsia Pharmaceuticals US INC | $36.15 | 2023 | Quviviq |
| Vertex Pharmaceuticals Incorporated | $24.38 | 2025 | |
| Shield Therapeutics INC | $17.75 | 2022 | |
| Abbvie INC. | $13.64 | 2021 | |
| Pfizer INC. | $13.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carly Strus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.